Compare TLSA & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLSA | CFBK |
|---|---|---|
| Founded | 2013 | 1892 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.2M | 184.4M |
| IPO Year | 2017 | 2005 |
| Metric | TLSA | CFBK |
|---|---|---|
| Price | $1.22 | $27.00 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $29.00 |
| AVG Volume (30 Days) | ★ 108.5K | 42.5K |
| Earning Date | 05-06-2025 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | N/A | ★ 30.58 |
| EPS | N/A | ★ 2.69 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $32.28 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $19.22 |
| 52 Week High | $2.60 | $34.34 |
| Indicator | TLSA | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 30.49 |
| Support Level | N/A | $23.79 |
| Resistance Level | $1.56 | $27.46 |
| Average True Range (ATR) | 0.09 | 0.84 |
| MACD | -0.01 | -0.34 |
| Stochastic Oscillator | 8.62 | 0.27 |
Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.